172 related articles for article (PubMed ID: 15494159)
1. Activation of programmed cell death markers in ventral horn motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in a transgenic mouse model.
Wengenack TM; Holasek SS; Montano CM; Gregor D; Curran GL; Poduslo JF
Brain Res; 2004 Nov; 1027(1-2):73-86. PubMed ID: 15494159
[TBL] [Abstract][Full Text] [Related]
2. Activation of the stress-activated MAP kinase, p38, but not JNK in cortical motor neurons during early presymptomatic stages of amyotrophic lateral sclerosis in transgenic mice.
Holasek SS; Wengenack TM; Kandimalla KK; Montano C; Gregor DM; Curran GL; Poduslo JF
Brain Res; 2005 May; 1045(1-2):185-98. PubMed ID: 15910777
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death.
Martin LJ; Liu Z; Chen K; Price AC; Pan Y; Swaby JA; Golden WC
J Comp Neurol; 2007 Jan; 500(1):20-46. PubMed ID: 17099894
[TBL] [Abstract][Full Text] [Related]
4. Adult motor neuron apoptosis is mediated by nitric oxide and Fas death receptor linked by DNA damage and p53 activation.
Martin LJ; Chen K; Liu Z
J Neurosci; 2005 Jul; 25(27):6449-59. PubMed ID: 16000635
[TBL] [Abstract][Full Text] [Related]
5. Neuronal nitric oxide synthase (nNOS) immunoreactivity in the spinal cord of transgenic mice with G93A mutant SOD1 gene.
Sasaki S; Warita H; Abe K; Iwata M
Acta Neuropathol; 2002 May; 103(5):421-7. PubMed ID: 11935256
[TBL] [Abstract][Full Text] [Related]
6. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
7. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations.
Raoul C; Estévez AG; Nishimune H; Cleveland DW; deLapeyrière O; Henderson CE; Haase G; Pettmann B
Neuron; 2002 Sep; 35(6):1067-83. PubMed ID: 12354397
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of scAAV9-IGF1 extends survival in SOD1
Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
[TBL] [Abstract][Full Text] [Related]
9. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
Wootz H; Weber E; Korhonen L; Lindholm D
Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
[TBL] [Abstract][Full Text] [Related]
10. Expression of hepatocyte growth factor and c-Met in the anterior horn cells of the spinal cord in the patients with amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS and familial ALS with superoxide dismutase 1 gene mutation.
Kato S; Funakoshi H; Nakamura T; Kato M; Nakano I; Hirano A; Ohama E
Acta Neuropathol; 2003 Aug; 106(2):112-20. PubMed ID: 12707786
[TBL] [Abstract][Full Text] [Related]
11. Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.
Shan X; Hu JH; Cayabyab FS; Krieger C
Neuroscience; 2005; 134(3):833-46. PubMed ID: 15994023
[TBL] [Abstract][Full Text] [Related]
12. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
13. Lack of involvement of neuronal nitric oxide synthase in the pathogenesis of a transgenic mouse model of familial amyotrophic lateral sclerosis.
Facchinetti F; Sasaki M; Cutting FB; Zhai P; MacDonald JE; Reif D; Beal MF; Huang PL; Dawson TM; Gurney ME; Dawson VL
Neuroscience; 1999; 90(4):1483-92. PubMed ID: 10338314
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic production of nerve growth factor in motor neuron apoptosis: implications for amyotrophic lateral sclerosis.
Pehar M; Cassina P; Vargas MR; Castellanos R; Viera L; Beckman JS; Estévez AG; Barbeito L
J Neurochem; 2004 Apr; 89(2):464-73. PubMed ID: 15056289
[TBL] [Abstract][Full Text] [Related]
15. Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.
Locatelli F; Corti S; Papadimitriou D; Fortunato F; Del Bo R; Donadoni C; Nizzardo M; Nardini M; Salani S; Ghezzi S; Strazzer S; Bresolin N; Comi GP
Ann Neurol; 2007 Jul; 62(1):81-92. PubMed ID: 17503505
[TBL] [Abstract][Full Text] [Related]
16. Reductions of docosahexaenoic acid-containing phosphatidylcholine levels in the anterior horn of an ALS mouse model.
Arima H; Omura T; Hayasaka T; Masaki N; Hanada M; Xu D; Banno T; Kobayashi K; Takeuchi H; Kadomatsu K; Matsuyama Y; Setou M
Neuroscience; 2015 Jun; 297():127-36. PubMed ID: 25841322
[TBL] [Abstract][Full Text] [Related]
17. Loss of Fas ligand-function improves survival in G93A-transgenic ALS mice.
Petri S; Kiaei M; Wille E; Calingasan NY; Flint Beal M
J Neurol Sci; 2006 Dec; 251(1-2):44-9. PubMed ID: 17049562
[TBL] [Abstract][Full Text] [Related]
18. Impairment of axonal transport in the axon hillock and the initial segment of anterior horn neurons in transgenic mice with a G93A mutant SOD1 gene.
Sasaki S; Warita H; Abe K; Iwata M
Acta Neuropathol; 2005 Jul; 110(1):48-56. PubMed ID: 15920660
[TBL] [Abstract][Full Text] [Related]
19. Inducible nitric oxide synthase (iNOS) and nitrotyrosine immunoreactivity in the spinal cords of transgenic mice with a G93A mutant SOD1 gene.
Sasaki S; Warita H; Abe K; Iwata M
J Neuropathol Exp Neurol; 2001 Sep; 60(9):839-46. PubMed ID: 11556540
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death.
Dewil M; dela Cruz VF; Van Den Bosch L; Robberecht W
Neurobiol Dis; 2007 May; 26(2):332-41. PubMed ID: 17346981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
